Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.

HB 125 amends Texas law to add three specific substances - carisoprodol (a muscle relaxant), mifepristone (a medication used in medical procedures), and misoprostol (a medication used in medical procedures) - to Schedule IV of the Texas Controlled Substances Act. This designation subjects these substances to stricter state-level regulation under Texas law, affecting law enforcement, pharmacies, and healthcare providers who handle them. The bill takes effect January 1, 2026, and applies only to offenses committed on or after that date. It does not change federal classifications or existing medical uses of these drugs.